Glycosylated yghj polypeptides from enterotoxigenic escherichia coli (ETEC)

a technology of enterotoxigenic escherichia coli and glycoprotein, which is applied in the field of glycoprotein-yghj polypeptides from, can solve the problems of significant negative health- and socio-economic impact of etec infection, complex discovery and characterization of glycoproteins, and poor ionization of peptides modified, and achieves the effect of improving the ionization efficiency of peptides

Inactive Publication Date: 2018-10-04
AARHUS UNIV +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The technical effect of this patent is that it describes how certain proteins can be used to make things like medicines and vaccines that help protect against an infection called ETEC.

Problems solved by technology

The technical problem addressed in this patent text is the lack of knowledge about the full complement of glycoproteins produced by enterotoxigenic Escherichia coli (ETEC), which causes most cases of human diarrhea. There are difficulties in identifying and mapping the location of glycans attached to proteins in bacteria due to the challenge of analyzing large amounts of data containing many different types of carbohydrates. However, discovering new glycoproteins can lead to better understanding of the mechanisms involved in bacterial pathogenesis and may provide valuable insights towards developing effective therapies against bacterial diseases like ETEC.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glycosylated yghj polypeptides from enterotoxigenic escherichia coli (ETEC)
  • Glycosylated yghj polypeptides from enterotoxigenic escherichia coli (ETEC)
  • Glycosylated yghj polypeptides from enterotoxigenic escherichia coli (ETEC)

Examples

Experimental program
Comparison scheme
Effect test

example 1

BEMAP Method Results

[0198]BEMAP relies on β-elimination of O-linked carbohydrate modifications, Michael addition of 2-Aminoethyl phosphonic acid (AEP) and TiO2 enrichment of phosphopeptides. Thus, BEMAP combines a firmly established in vitro chemical modification with a highly selective enrichment protocol (Thingholm et al., 2006) and the reactions take place in a single volume without the need for intermediate purification steps as described in the Experimental Procedures section.

[0199]The BEMAP method was first established using a synthetic mannosylated peptide as a model compound. As shown in FIG. 1A and 1B, MALDI MS demonstrated that BEMAP efficiently replaces the carbohydrate moiety of the synthetic peptide (m / z=1181.59 Da) with the AEP group and thus produces a phosphopeptide (m / z=1126.64 Da).

[0200]The overall efficiency of substitution exceeds 95% (FIG. 1B) without the formation of degradation products. The AEP-modified peptide was then strongly enriched using affinity chroma...

example 2

Immunogenicity of ETEC Glycosylated Proteins

[0215]An immunogenic polypeptide is defined as a polypeptide that induces an immune response.

[0216]The immune response may be monitored by one of the following methods: An in vitro cellular response is determined by release of a relevant cytokine such as IFN-γ, from lymphocytes withdrawn from an animal or human currently or previously infected with ETEC, or by detection of proliferation of these T cells. The induction is performed by addition of the polypeptide or the immunogenic part to a suspension comprising from 1×105 cells to 3×105 cells per well. The cells are isolated from either blood, the spleen, the liver or the lung and the addition of the polypeptide or the immunogenic part of the polypeptide result in a concentration of not more than 20 μg per ml suspension and the stimulation is performed from two to five days. For monitoring cell proliferation, the cells are pulsed with radioactive labeled Thymidine and after 16-22 hours of ...

example 3

Schematic Overview of Assays and Experiments Used to Characterize Glycosylated as Well as Non-Glycosylated YghJ Protein Properties

[0224]

TABLE 2Type of experimentMouse challengeSerum and mucosal antibody responsesAntibody mediated inhibition of ETEC binding to Caco-2Antibody mediated inhibition of ETEC binding to Caco-2; cAMP releasemeasurementDegradation of intestinal mucin MUC3Quantitative YghJ - MUC3 interaction assessmentDegradation of intestinal mucin MUC2

[0225]An overview of the assays used for testing a wide variety of YghJ features is given in Table 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Compositionaaaaaaaaaa
Login to view more

Abstract

The present invention relates to glycosylated YghJ poly-peptides from or derived from enterotoxigenic Escherichia coli (ETEC) that are immunogenic. In particular, the present invention relates to compositions or vaccines comprising the polypeptides and their application in immunization, vaccination, treatment and diagnosis of ETEC.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner AARHUS UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap